Recombinant Sinorhizobium medicae Ribosome-recycling factor (frr)

What is the ribosome-recycling factor (frr) in Sinorhizobium medicae and how does it function in bacterial translation?

Ribosome-recycling factor (frr) in Sinorhizobium medicae is a critical protein involved in the final stage of protein synthesis, specifically dissociating post-termination ribosomes into their constituent subunits. Similar to other bacterial recycling factors, S. medicae frr likely works in conjunction with elongation factor G (EF-G) to release the ribosome from mRNA after translation termination. This process is essential for maintaining ribosomal homeostasis by freeing ribosomal subunits for subsequent rounds of translation initiation. Unlike the eukaryotic system that primarily relies on Rli1/ABCE1 for recycling as seen in search result , bacterial systems typically utilize frr for this critical function.

How does the ribosome-recycling system in Sinorhizobium medicae compare to that of model organisms?

While the specific details of S. medicae ribosome recycling haven't been fully characterized, we can draw comparisons with better-studied systems. Unlike the eukaryotic recycling system described in search result , where Rli1/ABCE1 plays a central role in dissociating post-termination ribosomes into small and large subunits, bacterial systems typically utilize the ribosome-recycling factor (frr). The S. medicae system likely shares functional similarities with other Alpha-proteobacteria but may possess unique adaptations related to its symbiotic lifestyle with leguminous plants like Medicago species . The complete recycling process in bacteria generally involves three main components: ribosome-recycling factor (frr), elongation factor G (EF-G), and initiation factor 3 (IF3), working cooperatively to release mRNA, deacylated tRNA, and dissociate ribosomal subunits.

What are the optimal expression systems for producing recombinant S. medicae frr with high yield and purity?

Based on the expression patterns of other recombinant S. medicae proteins, E. coli remains the preferred heterologous expression system for recombinant frr production . For optimal results, consider using BL21(DE3) or Rosetta strains with pET-based vectors containing a 6×His-tag or other affinity tags for purification. Expression can be induced with IPTG (0.1-1.0 mM) at lower temperatures (16-25°C) for 4-16 hours to enhance solubility. Alternative expression systems may include yeast, baculovirus, or mammalian cell systems as mentioned for other S. medicae recombinant proteins in search result , particularly if post-translational modifications are required or if E. coli expression yields insoluble protein. The optimal system should achieve protein purity of at least 85% as determined by SDS-PAGE, consistent with standards for other recombinant S. medicae proteins .

What purification strategies are most effective for obtaining functional recombinant S. medicae frr?

A multi-step purification protocol is recommended for obtaining highly pure and functional recombinant S. medicae frr:

• Initial capture using affinity chromatography (IMAC with Ni-NTA resin for His-tagged constructs)

• Intermediate purification via ion-exchange chromatography (typically anion exchange using Q-Sepharose)

• Polishing step with size exclusion chromatography

Buffer composition is critical - typically containing 20-50 mM Tris-HCl or phosphate buffer (pH 7.5-8.0), 100-300 mM NaCl, and potentially 1-5 mM MgCl₂ to maintain structural integrity. Include protease inhibitors during initial lysis and early purification steps. For functional studies, avoid using EDTA which may chelate metal ions potentially important for frr activity. The final purity should exceed 85% as determined by SDS-PAGE analysis, consistent with quality standards for other recombinant S. medicae proteins .

How can researchers assess the structural integrity and functionality of purified recombinant S. medicae frr?

Multiple complementary approaches should be employed to confirm both structural integrity and functionality:

• Structural assessment:

  • Circular dichroism (CD) spectroscopy to confirm secondary structure content

  • Thermal shift assays to evaluate protein stability

  • Limited proteolysis to assess proper folding

  • Size-exclusion chromatography with multi-angle light scattering (SEC-MALS) to determine oligomeric state

• Functional assessment:

  • In vitro ribosome dissociation assays using purified S. medicae ribosomes

  • Polysome profile analysis to demonstrate recycling activity

  • Complementation assays in frr-depleted bacterial strains

  • GTPase activation assays with EF-G to verify functional interaction

When testing functionality, it's essential to include proper controls such as heat-denatured frr or known inactive frr mutants. Based on studies with ribosome recycling factors in other systems , the functionality of S. medicae frr would be confirmed by its ability to dissociate 70S ribosomes into 30S and 50S subunits in a factor-dependent manner.

What structural features distinguish S. medicae frr from other bacterial ribosome-recycling factors?

While specific structural information for S. medicae frr is limited in the provided search results, comparative structural analysis with other bacterial frr proteins suggests several key features:

• A conserved core domain with a three-layered β/α/β sandwich structure

• Critical surface residues involved in interactions with the ribosome and EF-G

• Potential unique surface loops or extensions specific to Alpha-proteobacteria

Structural differences may relate to the specialized symbiotic lifestyle of S. medicae, potentially including adaptations for function under the acidic conditions encountered during nodule formation, as mentioned for other S. medicae proteins in search result . Advanced structural studies using X-ray crystallography or cryo-EM would be necessary to identify structural features unique to S. medicae frr, particularly in comparison to frr proteins from related rhizobia and non-symbiotic bacteria.

How do mutations in key residues affect the function of S. medicae frr in ribosome recycling?

Based on structure-function studies in other bacterial species, several types of mutations would likely affect S. medicae frr function:

• Ribosome-binding interface mutations:

  • Alterations to positively charged residues (Arg, Lys) on the surface that interact with rRNA

  • Modifications to the domain interface that contacts the A site of the 30S subunit

• EF-G interaction residues:

  • Mutations in residues that coordinate with domain IV of EF-G

  • Changes to residues involved in stimulating the GTPase activity of EF-G

• Structural integrity mutations:

  • Alterations to hydrophobic core residues that maintain the protein fold

  • Disruption of conserved hydrogen bonding networks

Alanine-scanning mutagenesis combined with in vitro activity assays and complementation studies would be the preferred approach to systematically identify critical residues. Additionally, introducing compensatory mutations based on sequence alignments with frr from other species could provide insights into co-evolutionary adaptations specific to the S. medicae translational machinery.

What is the relationship between S. medicae frr activity and the symbiotic nitrogen fixation process?

The ribosome-recycling factor likely plays a critical role during the transition from free-living to symbiotic states in S. medicae. During nodule formation and bacteroid differentiation, S. medicae undergoes significant transcriptional and translational reprogramming to adapt to the symbiotic environment, as evidenced by studies in the related S. meliloti .

Proper ribosome recycling by frr would be essential during:

• The rapid growth phase following infection of root hairs

• The transition to bacteroid differentiation, where translation of specific symbiotic proteins is upregulated

• The establishment of mature nitrogen-fixing bacteroids with specialized metabolism

The lpiA gene in S. medicae WSM419, which enhances survival in acidic conditions typical of the rhizosphere-root interface, shows regulation dependent on environmental conditions , and similar environmental responsiveness may exist for frr. The essential nature of frr in maintaining translational homeostasis suggests it could be a critical factor in the successful establishment of the plant-microbe symbiosis, potentially affecting the efficiency of nitrogen fixation and ultimately plant growth, similar to other symbiosis factors described in search result .

How does S. medicae frr compare functionally to the orthologous protein in Sinorhizobium meliloti?

While specific comparative studies between S. medicae and S. meliloti frr are not detailed in the search results, analysis based on genomic information and studies of related proteins suggests:

• Sequence conservation: High sequence identity (likely >90%) would be expected between the frr proteins of these closely related species, with differences potentially concentrated in surface-exposed regions rather than the catalytic core.

• Functional conservation: Both proteins would maintain the core ribosome-recycling function, essential for bacterial viability and efficient translation in both free-living and symbiotic states.

• Host-specific adaptations: Subtle differences may exist that optimize each protein for the specific host legume interaction – S. medicae primarily nodulates Medicago species like M. truncatula while S. meliloti has a broader host range including alfalfa (M. sativa) .

Research from search result indicates that S. medicae WSM419 forms a more effective symbiosis with M. truncatula than S. meliloti Rm1021, suggesting potential differences in translation regulation during symbiosis that might involve differential activity of translation factors including frr.

What experimental approaches are effective for studying the evolution of ribosome-recycling factors across rhizobial species?

To study the evolution of ribosome-recycling factors across rhizobial species, researchers should consider:

• Phylogenetic analysis:

  • Construction of maximum-likelihood trees using frr sequences from diverse rhizobial species

  • Calculation of selection pressures (dN/dS ratios) to identify regions under positive, neutral, or purifying selection

  • Ancestral sequence reconstruction to trace the evolutionary trajectory of frr

• Functional complementation assays:

  • Cross-species complementation using frr genes from different rhizobia in conditional knockout strains

  • Quantification of complementation efficiency in both free-living and symbiotic states

  • Analysis of growth rates, translation efficiency, and symbiotic performance

• Chimeric protein analysis:

  • Creation of domain-swapped chimeras between frr proteins from different species

  • Identification of species-specific domains through functional testing

  • Correlation of domain functions with host specificity or environmental adaptation

This multifaceted approach would reveal how evolutionary pressures have shaped frr function across rhizobial species that have adapted to different host plants and environmental niches, potentially providing insights into the co-evolution of symbiotic relationships.

How do the mechanisms of ribosome recycling differ between S. medicae and eukaryotic systems?

The mechanisms of ribosome recycling differ significantly between S. medicae and eukaryotic systems in several key aspects:

• Key factors involved:

  • S. medicae likely utilizes the bacterial ribosome-recycling factor (frr) working with EF-G and IF3

  • Eukaryotes primarily use Rli1/ABCE1, which is an ATP-binding cassette protein, as described in search result

• Energy requirements:

  • Bacterial recycling with frr typically requires GTP hydrolysis by EF-G

  • Eukaryotic recycling via Rli1/ABCE1 depends on ATP hydrolysis

• Structural mechanism:

  • Bacterial frr inserts into the A site of the ribosome, pushing the P-site tRNA

  • Eukaryotic Rli1/ABCE1 binds near the translation factor binding site and uses ATP-driven conformational changes in its iron-sulfur cluster domains

• Coupling to termination:

  • In eukaryotes, recycling is tightly coupled to termination through interactions between Rli1/ABCE1 and eRF1

  • In bacteria, while recycling often follows termination, the process can also recycle ribosomes stalled during elongation

Search result provides detailed information on eukaryotic recycling mechanisms, highlighting that "unrecycled ribosomes queue at stop codons and reinitiate translation in 30UTRs," a phenomenon that may have different manifestations in bacterial systems like S. medicae.

How can recombinant S. medicae frr be utilized to study translational control during symbiotic nitrogen fixation?

Recombinant S. medicae frr can serve as a valuable tool for investigating translational control during symbiotic nitrogen fixation through several experimental approaches:

• In vitro translation systems:

  • Development of reconstituted S. medicae translation systems using purified components

  • Analysis of translational efficiency of symbiosis-specific mRNAs under varying frr concentrations

  • Investigation of how nodule-specific factors might modulate frr activity

• Protein-protein interaction studies:

  • Pull-down assays to identify interaction partners of frr during free-living vs. symbiotic states

  • Analysis of potential interactions with symbiosis-specific factors like those regulated by FcrX

  • Investigation of frr interactions with host plant factors during bacteroid development

• Conditional expression systems:

  • Creation of S. medicae strains with tunable frr expression

  • Analysis of global translation patterns (via ribosome profiling) under varying frr levels

  • Assessment of how altered frr levels affect bacteroid differentiation and nitrogen fixation efficiency

These approaches would provide insights into how translational control contributes to the remarkable cellular changes that occur during bacteroid differentiation, including the genome endoreduplication and increased cell size described in search result for the related S. meliloti.

What experimental design would best evaluate the impact of frr activity on S. medicae stress responses?

A comprehensive experimental design to evaluate the impact of frr activity on S. medicae stress responses would include:

Stage 1: Strain Construction

• Generate an S. medicae strain with the native frr promoter replaced by an inducible promoter

• Create point mutants with altered frr activity (hyperactive and hypoactive variants)

• Develop reporter strains with translational fusions to monitor frr expression

Stage 2: Stress Response Analysis

Stage 3: Molecular Analysis

• Ribosome profiling to identify mRNAs differentially translated under stress with varying frr levels

• Quantitative proteomics to correlate translational changes with protein abundance

• In vitro assays measuring frr activity under various stress conditions

This design would reveal how frr activity is modulated by environmental stresses relevant to the rhizobium-legume symbiosis, such as the acid stress that induces lpiA expression in S. medicae WSM419 as described in search result .

How could recombinant S. medicae frr be employed in developing improved bioinoculants for sustainable agriculture?

Recombinant S. medicae frr could contribute to developing improved bioinoculants through several strategic applications:

• Optimizing translational efficiency:

  • Engineering strains with fine-tuned frr expression to enhance translation of symbiosis genes

  • Using knowledge of frr regulation to create strains with improved protein synthesis under field conditions

  • Developing variants with enhanced activity at suboptimal temperatures or pH levels

• Cross-species enhancement:

  • Introduction of optimized S. medicae frr variants into related Sinorhizobium strains

  • Creation of chimeric frr proteins combining beneficial features from multiple rhizobial species

  • Transferring insights from S. medicae frr to enhance translation in other agricultural symbionts

• Stress tolerance improvement:

  • Engineering frr variants with enhanced function under acid stress, similar to the acid tolerance mechanisms described for lpiA in search result

  • Developing strains with coordinated expression of frr and other factors like FcrX to optimize cell cycle regulation during symbiosis

Such applications could lead to increased plant biomass, similar to the effects observed when modifying expression of other S. meliloti factors during nodule development . The symbiotic relationship between S. medicae and legumes like Medicago orbicularis already contributes to nitrogen fixation in agricultural settings , and enhancing translational efficiency through frr optimization could further improve this beneficial relationship.

What are common challenges in expressing and purifying active recombinant S. medicae frr and how can they be overcome?

Researchers frequently encounter several challenges when working with recombinant S. medicae frr:

Challenge 1: Low expression yields

• Solution: Optimize codon usage for the expression host; test multiple expression systems beyond E. coli (yeast, baculovirus, or mammalian cells as mentioned for other S. medicae proteins ); screen different fusion tags beyond His-tag; optimize induction conditions (temperature, IPTG concentration, induction time).

Challenge 2: Poor solubility

• Solution: Express at lower temperatures (16-18°C); co-express with chaperones (GroEL/ES, DnaK/J); use solubility-enhancing fusion partners (MBP, SUMO, TrxA); optimize buffer conditions with stabilizing additives (glycerol, arginine, trehalose).

Challenge 3: Impaired functionality

• Solution: Ensure presence of essential cofactors (Mg²⁺, K⁺); purify under reducing conditions to prevent disulfide formation; minimize freeze-thaw cycles; verify correct folding using circular dichroism or limited proteolysis.

Challenge 4: Protein aggregation during storage

• Solution: Optimize storage buffer composition (add glycerol, reduce salt concentration); store at appropriate temperature (typically -80°C with flash freezing); consider lyophilization with appropriate excipients.

What are the most reliable methods for quantifying the ribosome-recycling activity of S. medicae frr in vitro?

Several complementary methods can reliably quantify S. medicae frr activity:

• Light scattering assays:

  • Measure real-time dissociation of 70S ribosomes into 30S and 50S subunits

  • Advantages: Continuous monitoring, requires minimal sample preparation

  • Quantification: Calculate initial rates of dissociation under varying frr concentrations

• Sucrose density gradient analysis:

  • Separate and quantify ribosomal species (70S, 50S, 30S) following frr activity

  • Advantages: Directly visualizes ribosome profile changes, gold standard in the field

  • Quantification: Measure relative areas under peaks corresponding to each ribosomal species

• FRET-based assays:

  • Use fluorescently labeled ribosomal subunits to monitor dissociation

  • Advantages: High sensitivity, real-time monitoring, amenable to high-throughput

  • Quantification: Calculate FRET efficiency changes as a function of time and frr concentration

• GTP hydrolysis assays:

  • Measure EF-G-dependent GTP hydrolysis stimulated by frr

  • Advantages: Indirectly measures activity through nucleotide hydrolysis

  • Quantification: Determine the rate of inorganic phosphate release using malachite green or similar methods

Each method should include appropriate controls (no frr, heat-inactivated frr, non-hydrolyzable GTP analogs) and be performed under physiologically relevant conditions (pH, ion concentrations, temperature).

How can researchers effectively study the interaction between S. medicae frr and other components of the translation machinery?

To effectively study the interactions between S. medicae frr and other translational components, researchers should employ a multi-technique approach:

• In vitro binding assays:

  • Surface plasmon resonance (SPR) to determine binding kinetics (kon, koff) and affinity (KD)

  • Microscale thermophoresis (MST) for studying interactions in solution with minimal sample consumption

  • Isothermal titration calorimetry (ITC) to obtain thermodynamic parameters (ΔH, ΔS, stoichiometry)

• Structural studies:

  • Cryo-electron microscopy of frr-ribosome complexes at different functional states

  • X-ray crystallography of frr in complex with EF-G or ribosomal components

  • NMR spectroscopy to map interaction surfaces through chemical shift perturbations

• Cross-linking coupled with mass spectrometry:

  • Use of bifunctional cross-linkers to capture transient interactions

  • Photo-activatable unnatural amino acids for site-specific cross-linking

  • MS/MS analysis to identify cross-linked peptides and map interaction sites

• Genetic approaches:

  • Suppressor screens to identify compensatory mutations

  • Bacterial two-hybrid or split-protein complementation assays to verify interactions in vivo

  • Co-evolution analysis to identify potentially interacting residues

These approaches would enable mapping of the interaction network involving frr, similar to the techniques used to study FcrX interactions with CtrA and FtsZ in S. meliloti as described in search result , where "multiple complementary techniques" revealed important protein-protein interactions.

What emerging technologies could advance our understanding of S. medicae frr function in vivo?

Several cutting-edge technologies show promise for transforming our understanding of S. medicae frr function:

• CRISPR interference (CRISPRi) for conditional knockdown:

  • Allows titratable repression of frr expression without genetic modification

  • Enables temporal control of frr levels during different stages of symbiosis

  • Can be combined with RNA-seq or ribosome profiling for global impact assessment

• Single-molecule fluorescence microscopy:

  • Direct visualization of frr-ribosome interactions in living cells

  • Tracking of ribosome recycling events with single-molecule resolution

  • Correlation of recycling dynamics with cellular localization and bacteroid development

• Proximity-dependent labeling (BioID or APEX2):

  • Identification of the frr interactome in different growth conditions

  • Mapping temporal changes in frr interactions during symbiotic differentiation

  • Discovery of potential plant-derived factors that may interact with frr during symbiosis

• Nanopore direct RNA sequencing:

  • Detection of translation termination and recycling events at single-transcript resolution

  • Identification of mRNAs with altered recycling efficiency in frr-depleted conditions

  • Analysis of translation termination sites in the context of symbiosis-specific gene expression

These technologies could reveal how frr function is integrated with other aspects of S. medicae biology, particularly the cell cycle and differentiation processes that are critical for successful symbiosis, as highlighted in the related S. meliloti research described in search result .

How might structural data on S. medicae frr inform the development of new antimicrobials or symbiosis enhancers?

Detailed structural information on S. medicae frr could catalyze development in two key areas:

• Targeted antimicrobials:

  • Identification of structural differences between rhizobial and pathogenic bacterial frr proteins

  • Design of compounds that selectively inhibit frr from pathogenic bacteria while sparing beneficial rhizobia

  • Development of structure-based screening approaches for identifying natural products that differentially affect frr activity

• Symbiosis enhancers:

  • Rational design of frr variants with enhanced activity under symbiotic conditions

  • Identification of allosteric sites that could be targeted to modulate frr activity

  • Engineering of small molecules that stabilize frr-ribosome interactions during stress conditions

A structural analysis pipeline would include:

• High-resolution structure determination (X-ray crystallography or cryo-EM)

• Molecular dynamics simulations to identify potential binding pockets

• Structure-based virtual screening against compound libraries

• In vitro validation of hit compounds followed by in vivo testing in plant-microbe systems

This approach parallels the understanding gained from structural studies of other symbiosis factors, potentially leading to applications that could enhance plant biomass through improved nitrogen fixation, similar to the benefits observed with modified expression of other factors in S. meliloti .

What is the potential role of S. medicae frr in coordinating translation with nitrogen fixation efficiency?

The potential coordination between S. medicae frr activity and nitrogen fixation efficiency represents an intriguing research frontier:

• Metabolic coordination hypothesis:

  • frr activity may be modulated by metabolites specific to nitrogen fixation (e.g., NH₃, ATP/ADP ratio)

  • Translation of nitrogenase components could be preferentially enhanced through specialized recycling

  • Energy balance between translation and nitrogen fixation may be maintained through feedback to frr

• Developmental regulation:

  • frr expression or activity may be differentially regulated during bacteroid differentiation

  • Similar to how FcrX coordinates cell cycle and division in S. meliloti , frr may coordinate translation with developmental stages of bacteroid formation

  • Specific modification of frr during symbiosis could alter ribosome recycling efficiency on symbiosis-specific transcripts

• Stress response integration:

  • Low-oxygen environments in nodules may require specialized ribosome recycling

  • Acid stress responses (like those involving lpiA in S. medicae WSM419 ) may be coordinated with translation through frr

  • Plant-derived signals might modulate frr activity to synchronize bacterial translation with host developmental status